menu search

Intra-Cellular Therapies to Present at the Canaccord Genuity 43rd Annual Growth Conference

Intra-Cellular Therapies to Present at the Canaccord Genuity 43rd Annual Growth Conference
NEW YORK, Aug. 04, 2023 (GLOBE NEWSWIRE) — Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that it will present at the Canaccord Genuity 43rd Annual Growth Conference on Wednesday, August 9, 2023 at 1:30 p.m. ET. The live […] The post Intra-Cellular Therapies to Present at the Canaccord Genuity 43rd Annual Growth Conference appeared first on Fore... Read More
Posted: Aug 4 2023, 12:00
Author Name: forextv
Views: 102618

Search within

Pages Search Results: